Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week DHEA supplementation in menopausal women
2023-000224-10Phase 3Completed
- Sponsor
- Lek-AM
- Start
- Apr 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in menopause and female sexual dysfunction (FSD) comparing DHEA 35 mg with Placebo (2 arms). Started Apr 2023; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
menopausefemale sexual dysfunction (FSD)
Beyond the preview
Go deeper on 2023-000224-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-000224-10.